HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Louis M Staudt Selected Research

Louis M Staudt Research Topics

Disease

81Neoplasms (Cancer)
05/2024 - 01/2002
53Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2024 - 04/2002
39Lymphoma (Lymphomas)
04/2024 - 07/2002
18B-Cell Lymphoma (Lymphoma, B Cell)
12/2021 - 12/2002
13Burkitt Lymphoma (Burkitt's Lymphoma)
04/2024 - 06/2006
9Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 11/2005
7Disease Progression
10/2021 - 07/2002
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 07/2002
6Multiple Myeloma
01/2021 - 08/2007
5Leukemia
05/2017 - 07/2002
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2022 - 05/2014
3Genetic Translocation (Chromosomal Translocation)
12/2021 - 12/2002
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2021 - 01/2007
3Carcinogenesis
11/2009 - 04/2006
2Aspergillosis
05/2024 - 12/2017
2Anemia
01/2021 - 08/2017
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2019 - 05/2014
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2016 - 06/2003
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2013 - 08/2012
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
05/2013 - 08/2012
2Hematologic Neoplasms (Hematological Malignancy)
04/2012 - 05/2006
2Hodgkin Disease (Hodgkin's Disease)
03/2011 - 03/2010
2Plasmacytoma
11/2005 - 09/2005
2Infections
08/2004 - 04/2004
1Systemic Scleroderma (Systemic Sclerosis)
12/2023

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2002
16NF-kappa B (NF-kB)IBA
09/2010 - 07/2002
14Rituximab (Mabthera)FDA Link
04/2024 - 01/2007
12ibrutinibIBA
12/2021 - 02/2014
10DNA (Deoxyribonucleic Acid)IBA
10/2018 - 01/2002
9Prednisone (Sone)FDA LinkGeneric
01/2021 - 12/2011
9Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2011
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 12/2011
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 12/2011
8AntigensIBA
10/2021 - 01/2002
8Biomarkers (Surrogate Marker)IBA
05/2017 - 05/2003
7Agammaglobulinaemia Tyrosine KinaseIBA
05/2024 - 04/2015
7Transcription Factors (Transcription Factor)IBA
10/2018 - 05/2006
7Complementary DNA (cDNA)IBA
08/2007 - 04/2002
6LigandsIBA
04/2024 - 11/2005
6ParaffinIBA
05/2017 - 06/2011
6Phosphotransferases (Kinase)IBA
04/2016 - 06/2010
5Cyclin D1IBA
01/2021 - 02/2003
5CyclinsIBA
01/2021 - 12/2005
5Formaldehyde (Formol)FDA Link
05/2017 - 06/2011
5Messenger RNA (mRNA)IBA
01/2013 - 02/2003
4Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
04/2024 - 02/2014
4ChromatinIBA
01/2021 - 01/2012
4carboxyl radical (COO-)IBA
01/2021 - 06/2011
4Interleukin-6 (Interleukin 6)IBA
01/2020 - 09/2005
4Etoposide (VP 16)FDA LinkGeneric
01/2019 - 04/2013
4Immunoglobulin M (IgM)IBA
11/2015 - 04/2004
4MicroRNAs (MicroRNA)IBA
02/2015 - 09/2008
4RNA (Ribonucleic Acid)IBA
01/2013 - 08/2010
4Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
11/2005 - 06/2003
3Polysaccharides (Glycans)IBA
04/2024 - 10/2021
3UbiquitinIBA
12/2021 - 04/2014
3Lenalidomide (CC 5013)FDA Link
01/2021 - 06/2012
3Histones (Histone)IBA
01/2021 - 12/2010
3AntibodiesIBA
01/2019 - 10/2014
3Immunoglobulins (Immunoglobulin)IBA
02/2014 - 12/2002
3Bortezomib (Velcade)FDA Link
08/2012 - 06/2009
3I-kappa B KinaseIBA
06/2010 - 01/2005
3Cyclin D2IBA
11/2009 - 02/2004
2EpitopesIBA
04/2024 - 10/2014
2AutoantigensIBA
01/2023 - 11/2015
2Circulating Tumor DNAIBA
11/2022 - 01/2016
2Mechanistic Target of Rapamycin Complex 1IBA
10/2022 - 10/2021
2Ligases (Synthetase)IBA
12/2021 - 01/2015
2Histocompatibility Antigens Class IIBA
12/2021 - 01/2019
2Immunoglobulin Variable RegionIBA
10/2021 - 01/2019
2Protein Isoforms (Isoforms)IBA
01/2021 - 01/2021
2Cyclin D3IBA
10/2020 - 12/2005
2Anaplastic Lymphoma KinaseIBA
11/2019 - 05/2014
2Cytidine DeaminaseIBA
01/2019 - 03/2007
2Interleukin-10 (Interleukin 10)IBA
11/2016 - 04/2008
2Small Interfering RNA (siRNA)IBA
04/2016 - 11/2012
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2013 - 11/2009
2InterleukinsIBA
05/2013 - 02/2003
2ElementsIBA
11/2012 - 11/2009
2Tetracycline (Achromycin)FDA LinkGeneric
11/2012 - 05/2009
2InterferonsIBA
06/2012 - 04/2007
2MHC class II transactivator proteinIBA
03/2011 - 11/2009
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2009 - 01/2008
2Antigen Receptors (Antigen Receptor)IBA
03/2009 - 03/2008
1src-Family KinasesIBA
04/2024
1N-Acetylneuraminic Acid (Sialic Acid)IBA
04/2024
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2024
1polatuzumab vedotinIBA
04/2024
1GlucocorticoidsIBA
04/2024
1GlycosyltransferasesIBA
04/2024
1ChemokinesIBA
12/2023
1Janus Kinase InhibitorsIBA
10/2023
1Complement System Proteins (Complement)IBA
11/2022
1eprenetapoptIBA
10/2022
1palbociclibIBA
10/2022

Therapy/Procedure

30Therapeutics
01/2023 - 02/2003
9Drug Therapy (Chemotherapy)
01/2019 - 06/2002
7Precision Medicine
04/2024 - 01/2017
1Complementary Therapies (Alternative Medicine)
11/2022